Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Friday, November 22, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Myers Industries Appoints Aaron Schapper as CEO
Lunar Outpost Partners with SpaceX for Moon Mission
e3 Systems Partners with Rivada for Maritime Communications
Transformative Role of AI in the Automotive Industry
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Tumor Immunotherapy
Tumor Immunotherapy
Biotechnology
Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy
PR Newswire
-
June 28, 2022
Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets, announced research suggesting lenalidomide, a molecular...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Myers Industries Appoints Aaron Schapper as CEO
Lunar Outpost Partners with SpaceX for Moon Mission
e3 Systems Partners with Rivada for Maritime Communications
Load more
